Pharmafile Logo
Pharmafocus logo
Advanced Search
merck-keytruda

Keytruda + Inlyta combo beats Pfizer’s chemotherapy Sutent in renal cell carcinoma

February 12, 2019
Manufacturing and Production, Research and Development Cancer, MSD, Pfizer, inlyta, keytruda, pharma, renal cell carcinoma

New data has been revealed on the efficacy of MSD’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib), showing it …

News
5204602349_c87b204860_z

FDA to crack down on dietary supplements

February 12, 2019
Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes

The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …

News
gilead-sciences

Gilead shares drop 4% after failure of NASH drug to meet primary endpoint

February 12, 2019
Manufacturing and Production Gilead, Shares, fatty liver disease, nash, selonsertib

Gilead’s treatment for the progressive fatty liver disease, NASH, has failed to meet its primary goal in a phase 3 …

News
ai_pharmafocus

Solving the drug development problem

February 11, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, drug discovery, feature, pharma, pistoia alliance

Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …

Feature
vertex-headquarters

Vertex doubles Q4 profits, angering cystic fibrosis drug advocates in UK

February 11, 2019
Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma

Despite ongoing controversy surrounding the currently stalled negotiations between Vertex and the NHS to make its cystic fibrosis (CF) drug …

News
macaque-3714104_960_720

Scientists identify alcoholism gene

February 11, 2019
Research and Development, Sales and Marketing Alcohol misuse, alcoholism, ethanol, oregon, research

Scientists at the Oregon Health & Science University (OSHU) in Portland have identified a gene which may play a fundamental …

News

UCB teams up with charity to beat treatment-resistant epilepsy in $2.5m partnership

February 11, 2019
Research and Development, Sales and Marketing Epilepsy Society, UCB Pharma, epilepsy, pharma

Belgian firm UCB Pharma has announced a new partnership with the charity Epilepsy Society which will see the pair invest …

News
mosquito-1016254_1280

Diet drugs supress appetite in mosquitoes, study shows

February 11, 2019
Sales and Marketing Zika, dengue, infectuous diseases, malaria, mosquitoes

Scientists were able to supress mosquitoes appetites using diet drugs for humans, according to research published in the journal Cell. …

News

33% of antibiotics prescribed by NHS are given without associated diagnosis, England’s Chief Medical Officer warns

February 11, 2019
Sales and Marketing AMR, Antibiotics, Dame Sally Davies, England, UK, pharma

A third of the antibiotics prescribed by the NHS are given out despite there being no medical evidence that they …

News

Dame Sally Davis to step down as England’s CMO to become Master of Trinity College, Cambridge

February 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Professor Dame Sally Davies is set to step down from her roles as England’s Chief Medical Officer and as the …

Appointment

Researchers develop new, more effective method for detection of HIV virus genomes

February 8, 2019
Medical Communications, Research and Development HIV, University of Texas, pharma

A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing …

News
pat_smallcombe

Pat Smallcombe appointed chairman of J&J Consumer, EMEA

February 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson Consumer has appointed Pat Smallcombe to the position of Company Group Chairman, Europe, Middle East, Africa (EMEA). …

Appointment
shutterstock_3

FDA warns over breast implant cancer risk after nine deaths confirmed

February 8, 2019
Medical Communications, Research and Development Cancer, FDA, breast implants, pharma

The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, Merck, Pfizer, falsified medicines, strike, top 10

The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute …

News
28246711066_52e38bc591_z

FMD would not apply in case of no-deal Brexit

February 8, 2019
Medical Communications EU, FMD, UK, brexit, falsified medicines

The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British …

News

J&J to include prices in drug ads on TV

February 8, 2019
Medical Communications J&J, JJ, Johnson & Johnson, Trump, pharma, pricing

US multinational Johnson & Johnson has announced that it will include the price of its medicines in TV commercials for …

News
donato_spota

Hansa Biopharma names Donato Spota as new CFO

February 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Swedish firm Hansa Biopharma has appointed Donato Spota as the company’s new Chief Financial Officer (CFO). Spota will succeed current …

Appointment
chimerix_headshots_140x140_michelle-138x138

Chimerix CEO M. Michelle Berrey to stand down as interim Office of Cheif Executive Officer is formed

February 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The North Carolina-based biopharmaceutical company Chimerex has announced that Dr M. Michelle Berrey has resigned from her role as President …

Appointment
shutterstock_360472550

Eisai and Purdue reveal positive Phase 3 data in insomnia

February 7, 2019
Research and Development Eisai, Purdue Pharma, insomnia, lemborexant, pharma

Partners Eisai and Purdue Pharma have lifted the curtain on Phase 3 clinical data on their jointly developed therapy lemborexant …

News
white-house-13863_960_720

Pharma chiefs will testify at Senate hearing on rising drug prices

February 7, 2019
Sales and Marketing CEO, J&J, JJ, Pfizer, Sanofi, Senate, pharma, pricing

The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026